CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 5,000 shares (grant or award)
- 4/A Open-market buy Chief Scientific Officer bought 12,000 shares at $10.00 ($120,000)
- 4 Open-market buy Director bought 100 shares at $8.05 ($805)
- 4 Open-market buy Director bought 100,000 shares at $10.00 ($1,000,000)
- 4 Returned to the company Director returned 5,000 shares (to the company)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market buy Chief Scientific Officer bought 103,000 shares at an average $9.98 ($1,028,230)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 12 of 13 · 246 filings